公开(公告)号：US20060240094A1

公开(公告)日：2006-10-26

申请号：US10566541

申请日：2004-07-30

申请人： Yuzo Asano ,  Kyoichi Oshida ,  Takanori Kobayashi

发明人： Yuzo Asano ,  Kyoichi Oshida ,  Takanori Kobayashi

IPC分类号： A61K9/48 ,  A61K9/64

CPC分类号： A61K9/4833 ,  A23P10/30 ,  A61K9/0056 ,  A61K9/4825

摘要： This chewable capsule has an encapsulating shell and a filling contained within the encapsulating shell, in which outer diameter of the above encapsulating shell ranges from 14 mm to 25 mm, and mass of the above encapsulating shell ranges from 10% to 20% of the total mass of the chewable capsule, the quantity of the above filling contained within the above encapsulating shell ranges from 1400 mg to 3000 mg, and gelatin is contained in the above encapsulating shell.

摘要翻译： 该咀嚼胶囊具有包封壳和包封在包封壳内的填充物，其中上述包封壳的外径范围为14mm至25mm，并且上述包封壳的质量范围为总量的10％至20％ 可咀嚼胶囊的质量，上述包封壳中所含的上述填充物的量为1400mg至3000mg，并且上述包封壳中含有明胶。

公开(公告)号：US08414917B2

公开(公告)日：2013-04-09

申请号：US12422717

申请日：2009-04-13

申请人： Yuzo Asano ,  Kyoichi Oshida ,  Takanori Kobayashi

发明人： Yuzo Asano ,  Kyoichi Oshida ,  Takanori Kobayashi

IPC分类号： A61K9/48

CPC分类号： A61K9/4833 ,  A23P10/30 ,  A61K9/0056 ,  A61K9/4825

摘要： This chewable capsule has an encapsulating shell and a filling contained within the encapsulating shell, in which outer diameter of the above encapsulating shell ranges from 14 mm to 25 mm, and mass of the above encapsulating shell ranges from 10% to 20% of the total mass of the chewable capsule, the quantity of the above filling contained within the above encapsulating shell ranges from 1400 mg to 3000 mg, and gelatin is contained in the above encapsulating shell.

摘要翻译： 该咀嚼胶囊具有包封壳和包封在包封壳内的填充物，其中上述包封壳的外径范围为14mm至25mm，并且上述包封壳的质量范围为总量的10％至20％ 可咀嚼胶囊的质量，上述包封壳中所含的上述填充物的量为1400mg至3000mg，并且上述包封壳中含有明胶。

公开(公告)号：US20090194893A1

公开(公告)日：2009-08-06

申请号：US12422717

申请日：2009-04-13

申请人： Yuzo Asano ,  Kyoichi Oshida ,  Takanori Kobayashi

发明人： Yuzo Asano ,  Kyoichi Oshida ,  Takanori Kobayashi

IPC分类号： B01J13/20

CPC分类号： A61K9/4833 ,  A23P10/30 ,  A61K9/0056 ,  A61K9/4825

摘要： This chewable capsule has an encapsulating shell and a filling contained within the encapsulating shell, in which outer diameter of the above encapsulating shell ranges from 14 mm to 25 mm, and mass of the above encapsulating shell, ranges from 10% to 20% of the total mass of the chewable capsule, the quantity of the above filling contained within the above encapsulating shell ranges from 1400 mg to 3000 mg, and gelatin is contained in the above encapsulating shell.

摘要翻译： 该可咀嚼胶囊具有包封壳和包封在包封壳内的填充物，其中上述包封壳的外径范围为14mm至25mm，并且上述包封壳的质量为10至20％ 可咀嚼胶囊的总质量，上述包封壳中所含的上述填充物的量为1400mg至3000mg，上述包封壳中含有明胶。

公开(公告)号：US06867234B2

公开(公告)日：2005-03-15

申请号：US10415412

申请日：2001-11-15

申请人： Yasunobu Antoku ,  Kosuke Tsukamoto ,  Fumihiko Koike ,  Takashi Tokuyama ,  Hirotoshi Hayasawa ,  Mitsunori Takase ,  Kyoichi Oshida

发明人： Yasunobu Antoku ,  Kosuke Tsukamoto ,  Fumihiko Koike ,  Takashi Tokuyama ,  Hirotoshi Hayasawa ,  Mitsunori Takase ,  Kyoichi Oshida

IPC分类号： A61K31/232 ,  A61P3/00 ,  A61P43/00 ,  A61K31/20 ,  A61K31/07 ,  A61K31/23 ,  A61K31/59

CPC分类号： A61K31/232

摘要： A fat composition for oral or enteral administration which contains eicosapentaenoic acid and/or a derivative thereof, docosahexaenoic acid and/or a derivative thereof, and a C20 or higher monoenoic acid and/or a derivative thereof and functions to diminish hexacosanoic acid; and a hexacosanoic acid depressant which comprises as active ingredients eicosapentaenoic acid and/or a derivative thereof, docosahexaenoic acid and/or a derivative thereof, and a C20 or higher monoenoic acid and/or a derivative thereof. They can be prepared by extraction from a fish oil or the like, purification, blending, etc. Based on the function of diminishing hexacosanoic acid, the composition and the depressant produce an aging-inhibitory effect on cell membranes, which is effective in the prevention and treatment of lifestyle-related diseases.

摘要翻译： 用于口服或肠内给药的脂肪组合物，其包含二十碳五烯酸和/或其衍生物，二十二碳六烯酸和/或其衍生物，以及C20或更高级的单烯酸和/或其衍生物，并且具有减少二十六烷酸的功能; 和二十碳三烯酸抑制剂，其包含二十碳五烯酸和/或其衍生物，二十二碳六烯酸和/或其衍生物，以及C20或更高级的单烯酸和/或其衍生物作为活性成分。 它们可以通过从鱼油等中提取，纯化，混合等制备。基于减少二十五烷酸的功能，组合物和抑制剂对细胞膜产生抑制老化的作用，这对预防有效 和生活方式相关疾病的治疗。